Skip to main content
. 2022 Mar 3;12:3560. doi: 10.1038/s41598-022-07187-3

Figure 4.

Figure 4

Acquisition of serum and whole blood samples from healthy controls and patients. (A) Blood samples were collected from healthy controls and patients (B). One whole blood sample was sent directly for immunophenotyping. Additional blood samples were placed into tubes containing gold-microparticles and incubated at 37 °C for 24 h. After incubation, samples were centrifuged to remove microparticles and blood cells, and serum was decanted. The decanted serum was used for further analysis. In addition, the serum was re-injected into the patients for therapy treatment. *After the second treatment with autologous serum (before they received the third injection) another sample was generated for analysis. CC By Jörg Pekarsky.